Yi Zhang | Health Sciences | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Yi Zhang | Health Sciences | Best Researcher Award

Prof. Yi Zhang | Health Sciences | Best Researcher Award 🏆

Director/Academic Vice President at Biotherapy Center, The First Affiliated Hospital of Zhengzhou University/Zhengzhou University School of Medical Sciences🎓

Prof. Yi Zhang is an internationally acclaimed expert in cell and tumor immunotherapy. Serving as Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, he also holds key leadership roles, including Academic Vice President of the Zhengzhou University School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. With 35 years of research experience across Belgium, the U.S., and China, Prof. Zhang has pioneered breakthrough therapies, such as genetically engineered CAR-T cells for solid tumors, and holds 16 patents. His work has made significant impacts in reducing immune suppression and improving cancer treatment efficacy worldwide.

Professional Profile 

Education 🎓:

Prof. Yi Zhang has a profound academic foundation in medical sciences, gained through decades of experience and study in Belgium, the United States, and China. His extensive education and training have built the groundwork for his pioneering research in cell and tumor therapy.

Work Experience 💼:

Prof. Zhang is the Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, where he also serves as the Academic Vice President for Zhengzhou University’s School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. Over a 35-year career, he has developed innovative therapies and led cutting-edge research in cell therapy, accumulating extensive clinical and academic expertise.

 

Skills 🔍

Known for his skills in genetically engineered cell therapies, Prof. Zhang is a leader in cellular engineering, particularly CAR-T cell technology. His groundbreaking work includes discovering a therapeutic target for solid tumors and developing gene-editing techniques to improve immune responses. His practical expertise in cell culture, immune cell enhancement, and patent development make him a pioneer in clinical biotherapeutics.

Awards and Honors 🏆

Prof. Zhang has received acclaim globally, being listed among the world’s top 100,000 scientists and recognized by both domestic and international peers for his contributions to immunotherapy. He has successfully converted seven patents, raising over 80 million RMB in transfer amounts, and is frequently invited to international conferences as a distinguished chair or guest of honor.

🤝 Memberships:

Prof. Zhang holds numerous prominent roles, such as Chairman of the Committee on Tumor Immunity and Biotherapy, Chinese Society of Immunology, and Deputy Chairman of the Cancer Biological Therapy Committee under the China Anti-Cancer Association. He also plays leadership roles in the Henan Anticancer Association and Henan Immunological Society, reflecting his commitment to advancing cell therapy on a national and global scale.

Teaching Experience 👩‍🏫:

Prof. Zhang has contributed significantly to training the next generation of scientists, collaborating with international colleagues to co-train PhD students and mentor young researchers. His commitment to academic growth is evident through his regular academic exchanges and collaborative projects with institutions in Canada, the U.S., and Europe.

Research Focus 🔬:

Prof. Zhang’s research is concentrated on tumor immunotherapy and cellular therapy, focusing on advancing CAR-T cell therapies for cancer. His achievements include creating novel immune cell treatments, reducing PD-1 expression to combat immune suppression, and conducting over 52 clinical trials for new cancer therapies, with 29 specifically targeting solid tumors.

Conclusion 

Prof. Yi Zhang stands as an exemplary candidate for the Best Researcher Award due to his substantial contributions to the field of cellular immunotherapy and cancer research. His achievements align closely with the award’s goals of recognizing innovation, impactful research, and contributions to society. With his strengths in pioneering therapy innovations and significant clinical applications, Prof. Zhang’s work exemplifies the award’s spirit, making him a distinguished candidate for the Best Researcher Award.

📚 Publilcation

  • “LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy”
    • Year: 2024-12-31
    • Journal: OncoImmunology
  • “Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy”
    • Year: 2024-11
    • Journal: European Journal of Immunology
  • “CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis”
    • Year: 2024-10-03
    • Journal: Cancer Immunology Research
  • “A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues”
    • Year: 2024-10-01
    • Journal: Scientific Data
  • “Allogeneic CAR-T cells for cancer immunotherapy”
    • Year: 2024-09-24
    • Journal: Immunotherapy
  • “IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells”
    • Year: 2024-05-03
    • Journal: British Journal of Cancer
  • “Current advances in bacteria‐based cancer immunotherapy”
    • Year: 2024-02
    • Journal: European Journal of Immunology
  • “Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity”
    • Year: 2023-10-09
    • Journal: Cancer Biology & Medicine
  • “Immunosenescence: molecular mechanisms and diseases”
    • Year: 2023-05-13
    • Journal: Signal Transduction and Targeted Therapy
  • “Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells”
    • Year: 2023-04-28
    • Journal: Signal Transduction and Targeted Therapy

Marcelo soares | Health Sciences | Excellence in Research

Posted on by sciencefatherLeave a Comment on Marcelo soares | Health Sciences | Excellence in Research

Prof. Dr. Marcelo soares | Health Sciences | Excellence in Research

Researcher at Osteogenesis Institute, Brazil

Dr. Marcelo Melo Soares has an extensive background in oral and maxillofacial surgery, with over 35 years of experience in clinical practice and research. He holds advanced degrees, including a PhD in Translational Surgery and a postdoctoral fellowship in Material Engineering and Nanotechnology. His research primarily focuses on bone regeneration, stem cell therapies, and nanomaterials, and he has published numerous papers in high-impact journals. Dr. Soares has made significant contributions to the field of maxillofacial surgery, particularly in the areas of distraction osteogenesis and zygomatic implants, making him a strong candidate for the Excellence in Research award.

 

Professional Profile 

🎓 Education

Dr. Marcelo Soares earned his degree in Dentistry from the Universidade Estadual de Campinas in 1986. He completed his Master’s in Oral and Maxillofacial Surgery at UNIP in 1998, and later pursued his PhD in Translational Surgery at the Universidade Federal de São Paulo (UNIFESP) in 2016. His postdoctoral research at Mackenzie Presbyterian University focused on Material Engineering and Nanotechnology, further broadening his expertise in developing innovative surgical and biomedical solutions.

 

🏢 Work Experience

Prof. Dr. Marcelo Soares has held significant academic and clinical positions throughout his career. From 1988 to 2007, he served as an Assistant Professor in the Department of Oral and Maxillofacial Surgery at the Hospital Universitário of São Paulo. Currently, he practices as a lead surgeon across several renowned hospitals in São Paulo, including Oswaldo Cruz, Santa Catarina, and Rede D’Or. In addition to his clinical work, he is actively involved in research projects focused on tissue engineering, stem cell therapies, and nanotechnology applied to oral surgery.

 

🧬 Skills

Dr. Soares is an expert in oral and maxillofacial surgery, with specialized skills in bone regeneration, zygomatic implants, orthognathic surgery, and reconstructive procedures. His cutting-edge work in nanotechnology and stem cell therapies highlights his multidisciplinary approach to improving surgical outcomes. His research and clinical work emphasize distraction osteogenesis, as well as the development of advanced biomaterials and scaffolds for tissue regeneration.

Awards and Honors 🏆

Throughout his distinguished career, Dr. Soares has received numerous awards, including recognition from the Portuguese Society of Orthodontics and the Ulises Guimarães Medal from the Brazilian Parliamentary Order. His research and clinical contributions have been widely acknowledged, and his work continues to influence both academic and clinical communities. His projects funded by CAPES and CNPq further highlight his leadership in groundbreaking research.

Membership 🤝

Dr. Soares is an active member of several professional organizations, including the Brazilian Society of Oral and Maxillofacial Surgery, the International Association of Oral and Maxillofacial Surgeons, and the Brazilian Society of Tissue Engineering and Regenerative Medicine. His memberships reflect his ongoing commitment to staying at the forefront of advancements in both surgical and biomedical fields.

Teaching Experience 📚

As an educator, Dr. Soares has been a mentor to countless students and residents, particularly during his tenure as an Assistant Professor at the Hospital Universitário of São Paulo. He has also served as a Preceptor of the Residency Program in Oral and Maxillofacial Surgery. His teaching has shaped the next generation of surgeons, particularly in the fields of complex reconstructive surgery and implantology.

🔬 Research Focus

Dr. Soares’ research is centered on bone regeneration, nanotechnology, and stem cell therapy for maxillofacial reconstruction. His work involves developing new materials and techniques, such as PLLA/GO scaffolds for bone repair and 3D-printed biocomposites, aimed at improving surgical outcomes. His research not only enhances clinical practices but also contributes to the advancement of tissue engineering and biotechnology.

Conclusion 

Dr. Marcelo Melo Soares is an excellent candidate for the Excellence in Research award, given his extensive contributions to maxillofacial surgery and innovative research in tissue engineering and nanotechnology. His commitment to advancing both clinical practice and research makes him a leader in his field. By increasing international collaborations and focusing on translating his research into clinical applications, he could further expand his impact on the global stage.

 

📚 Publication 

Angular Analysis of the Decay

Authors: R Aaij, CA Beteta, T Ackernley, B Adeva, M Adinolfi, H Afsharnia, …

Citations: 215

Year: 2021

Distraction Osteogenesis in Goldenhar Syndrome: Case Report and 8-Year Follow-Up

Authors: MDM Lima, YMFS Marques, SM Alves Júnior, KL Ortega, MM Soares, …

Citations: 39

Year: 2007

Cyclic DSS Tests for the Evaluation of Stress Densification Effects in Liquefaction Assessment

Authors: AV Da Fonseca, M Soares, AB Fourie

Citations: 38

Year: 2015

Measurement of Pseudorapidity Distributions of Charged Particles in Proton–Proton Collisions at TeV by the CMS and TOTEM Experiments

Authors: CMS and TOTEM Collaborations

Citations: 37

Year: 2014

Factors Affecting Steady State Locus in Triaxial Tests

Authors: M Soares, AV Fonseca

Citations: 32

Year: 2016

Measurement of the Shape of the Differential Decay Rate

Authors: R Aaij, C Abellán Beteta, T Ackernley, B Adeva, M Adinolfi, H Afsharnia, …

Citations: 17

Year: 2020

Coimbra Sand–Round Robin Tests to Evaluate Liquefaction Resistance

Authors: JA Santos, RC Gomes, JC Lourenço, F Marques, P Coelho, R Azeiteiro, …

Citations: 14

Year: 2012

Distração Osteogênica: Revisão de Literatura

Authors: M Nacao, GC Dominguez Rodriguez, MM Soares

Citations: 10

Year: 2002

Effect of Principal Stress Rotation on Cyclic Liquefaction

Authors: A Viana da Fonseca, M Soares

Citations: 8

Year: 2012

Dental Team Management for a Patient with Klippel–Feil Syndrome: Case Report

Authors: M De Deus Moura de Lima, KL Ortega, LCA Araújo, MM Soares, …

Citations: 8

Year: 2009